Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEXIMMUNE-INC-118850398/news/Neximmune-to-Highlight-Preliminary-Results-from-Phase-1-2-Trial-of-NEXI-001-Via-Oral-Presentation-at-33637840/?utm_source=whatsapp&utm_medium=social&utm_campaign=share